Related Experiment Videos
A hypothesis for the pathogenesis of myelodysplastic syndromes: implications for new therapies
1Texas Oncology, PA, Dallas, TX 75230, USA.
Abstract:
To guide development of new clinical strategies, a review of recent investigations in the pathobiology of MDS was performed. Articles were identified through a Medline search. Studies, including reviews, are cited in the references. A multistep pathogenesis is proposed. (1) Targeted injury or mutation within hemopoietic stem cells may be followed by an immunologic response adversely affecting progenitor survival. (2) Accelerated proliferation and premature death of marrow cells is amplified by apoptogenic cytokines (TNF-alpha, Fas ligand). (3) Establishment of an abnormal clone associated with telomere shortening. (4) Disease progression associated with loss of tumor suppressor activity. Opportunities for therapeutic interventions are possible at each step. Comparisons between the proposed pathogenesis of MDS and severe aplastic anemia (SAA) are also presented. Leukemia (2000) 14, 2-8.
Insights
This review proposes a multistep pathogenesis for myelodysplastic syndromes (MDS), involving stem cell injury, immune response, abnormal clone establishment, and tumor suppressor loss. Therapeutic interventions are possible at each stage of MDS development.
Area of Science:
- Hematology
- Pathobiology
- Stem Cell Biology
Background:
- Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders.
- Understanding the pathobiology of MDS is crucial for developing effective clinical strategies.
Purpose of the Study:
- To review recent investigations into the pathobiology of myelodysplastic syndromes (MDS).
- To propose a multistep pathogenesis for MDS.
- To identify potential therapeutic intervention points.
Main Methods:
- A comprehensive literature review of recent investigations in MDS pathobiology.
- Medline database search for relevant articles, including reviews.
- Analysis and synthesis of findings to propose a pathogenic model.
Main Results:
- A four-step multistep pathogenesis for MDS is proposed:
- 1. Targeted injury/mutation in hematopoietic stem cells followed by an adverse immunologic response.
- 2. Accelerated proliferation and premature marrow cell death amplified by apoptogenic cytokines (e.g., TNF-alpha, Fas ligand).
- 3. Establishment of an abnormal clone linked to telomere shortening.
- 4. Disease progression associated with loss of tumor suppressor activity.
Conclusions:
- The proposed multistep pathogenesis offers a framework for understanding MDS development.
- Therapeutic interventions are potentially feasible at each identified stage of MDS pathogenesis.
- Comparisons with the pathogenesis of severe aplastic anemia (SAA) are also discussed.